The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes

Medical Science Monitor

Volumn 9, Issue 9, 2003, Pages

  Gajewicz, Witold ^a   Papierz, Wielisław ^a   Szymczak, Wiesław ^b   Goraj, Bozena ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

1H MRS; Brain inflammatory lesions; Brain neoplasms; MRI

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; RELIABILITY; TUMOR BIOPSY; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

ADULT; AGED; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOBLASTOMA; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; NEOPLASM METASTASIS; OLIGODENDROGLIOMA; PROTONS; SENSITIVITY AND SPECIFICITY;

EID: 0142090384     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alger JR, Cloughesy TF: Structural and functional imaging of cerebral neoplasia. In: Mazziotta J C, Toga AW, Frackowiak RS (eds). Brain-mapping the disorders. Academic Press. San Diego, 2000; 387-416
2. Kubicki M, Goraj B, Zakrzewski K, Liberski P: Proton magnetic resonance spectroscopy of pediatric brain tumors. Pol Przegl Radiol, 1999; 64: 210-13
3. Bruhn H, Frahm J, Gyngell M et al: Noninvasive differentiation of tumors with use of localized HI MR spectroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology, 1989; 172: 541-8
4. Tarasow E, Kubas B, Walecki J: MR proton spectroscopy in patients with CNS involvement in Bourneville's disease. Med Sci Monit, 2001; 7: 762-765
5. Tarasow E, Siergiejczyk L, Panasiuk A et al: MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit, 2002; 8: MT36-40
6. Negendank W, Sauter R, Brown T et al: Proton magnetic resonance spectroscopy in patients with glial tumors. A multicenter Study. J Neurosurg, 1996; 84: 449-58
7. Preul M, Caramanos Z, Colins D et al: Accurate noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med, 1996; 9: 323-5
8. Szabo de Edelenyi F, Rubin C, Esteve F et al: A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med, 2000; 16: 1287-9
9. Fisher LD, van Belle G: Biostatistics: A methodology for the health sciences. Wiley-Interscience Publication, John Wiley & Sons Inc. New York, 1993
10. Kleihues P, Cavenee WK: Pathology and Genetics of Tumors of the Nervous System. IARC Press, Lyon, 2000
11. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med, 1993; 30: 672-9
12. 1H MRSI. Proc Intl Soc, Mag Reson Med, 2001; 9: 2304
13. Ott D, Hennig J, Ernst T: Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology, 1993; 186: 745-52
14. Herminghaus S, Pilatus U, Setzer M et al: Pathologic metabolism of neuroepithelial brain tumors: prognostic impact of total choline compounds and lipids as measured with in vivo proton MR spectroscopy. Proc Intl Soc, Mag Reson Med, 2001; 9: 276
15. 1H MRS of neutral lipids in low and high grade gliomas, recurrent gliomas, lymphomas, abscesses and inflammation. Proc Intl Soc, Mag Reson Med, 2001; 9: 270
16. 1H MRSI. NMR Biomed, 1999; 12: 123-38
17. Moore GJ: Proton magnetic resonance spectroscopy in pediatric neuroradiology. Pediatr Radiol, 1998; 28: 805-14
18. Rubaek Danielsen E, Ross B: Magnetic resonance spectroscopy diagnosis of neurological diseases. Marcel Dekker, Inc New York, 1999
19. 1H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate. Magn Reson Med, 1999; 42: 1155-8
20. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med, 1997; 37: 222-5
21. Lin A, Ross BD: The effect of gadolinium on quantitative short-echo time single voxel MRS of treated and untreated brain tumors. Proc Intl Soc, Mag Reson Med, 2000; 9: 270
22. Smith JK, Kwock L, Castillo M: Effects of contrast material on single-volume proton MR spectroscopy. Am J Neuroradiol, 2000; 21: 1084-9
23. Poumels PJ, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn. Reson. Med, 1998; 39: 53-60
24. Sijens PE, den Heijet T, De Leeuw FE et al: MR spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people. Eur Radiol, 2001; 11: 1495-1501
25. Hagberg G, Burlina AP, Mader I et al: In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi dimensional classification. Magn Reson Med, 1993; 34: 242-52
26. 1H MR spectroscopy. Radiology, 1992; 183: 701-9
27. 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med, 1995; 33: 818-26
28. Shino A, Nakasu S, Matsuda M et al: Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg, 1999; 91: 928-34
29. Helms G, Stawiarz L, Kivisakk P, Link H: Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions. Magn Reson Med, 2000; 43: 102-10
30. Roser W, Hagberg G, Mader I et al: Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal appearing white matter. Magn Reson Med, 1995; 33: 811-17
31. Castillo M, Smith JK, Kwock L: Correlation of myoinositol levels and grading of cerebral astrocytomas. Am J Neuroradiol, 2000; 21: 1645-9
32. 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumors. Acta Neurochir Suppl, 1997; 68: 127-32